Vimarsana
Biggest News Aggregation in the World

Page 42 - Roche Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roche Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roche Diagnostics Today - Breaking & Trending Today

Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent Director - Vimarsana News

Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent Director

23.05.2023 - REDWOOD CITY, Calif., May 23, 2023 (GLOBE NEWSWIRE) - Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of ... Seite 1

Congress weighs stiffer fentanyl regulations - Vimarsana News

Congress weighs stiffer fentanyl regulations

According to recent provisional CDC data, nearly 80,000 people died last year of an opioid overdose. Of those, more than 72,000 deaths were linked to synthetic opioids like fentanyl.

Global Clinical Chemistry Analyzer Market Size To Worth - Vimarsana News

Global Clinical Chemistry Analyzer Market Size To Worth

The Global Clinical Chemistry Analyzer Market Size was valued at USD 15.01 Billion in 2021 and the worldwide clinical chemistry analyzer market size is...

COVID-19: Do Not Use These At-Home Tests Due To Bacteria Concerns, FDA Says - Vimarsana News

COVID-19: Do Not Use These At-Home Tests Due To Bacteria Concerns, FDA Says

Americans have been advised by federal officials not to use a brand of COVID-19 at-home tests that could have potentially harmful bacteria inside the kits.SD Biosensor, Inc. announced on Friday, May 5, that the company is requesting that c…

Blood Coagulation Analyzers Market is likely to grow to a valuation of US$ 5,723.7 Million by 2032 a - Vimarsana News

Blood Coagulation Analyzers Market is likely to grow to a valuation of US$ 5,723.7 Million by 2032 a

The global Blood Coagulation Analyzers Market size is likely to be valued at US$ 2,857.4 Million in 2022 and is expected to reach US$ 5,723.7 Million in 2032. The sales of blood coagulation Analyzers are anticipated to grow at a CAGR of 6.5% during the forecast period.FMI, in its business report, elaborates the hist...